CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in ARCT — Arcturus Therapeutics Holdings Inc.
CIK 884546
SAN FRANCISCO, CA
Position in ARCT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,556,540
-$114,840 QoQ
Shares Held
231,628
+7.0% QoQ
Ownership
0.815%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#20
of 133 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARCT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,346,663,053 across 299 Biotechnology names. ARCT ranks #201 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,041,282 | $1,013,966,007 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846,306 | $527,705,642 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,917,025 | $359,020,441 | |
| 4 | MRNA |
Moderna, Inc.
|
4,838,884 | $338,867,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
755,377 | $227,391,137 | |
| 6 | INCY |
Incyte Corp
|
1,692,439 | $191,854,884 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,083,528 | $172,893,414 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,565,781 | $133,388,883 |
All Filings in ARCT
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,556,540 | 231,628 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,671,380 | 216,500 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,127,031 | 183,855 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $3,860,274 | 209,456 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $2,472,901 | 190,077 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $2,061,121 | 194,629 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $3,526,399 | 207,802 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $4,586,806 | 197,622 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $4,733,591 | 194,398 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $6,442,167 | 190,766 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $5,874,354 | 186,310 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $4,699,692 | 183,941 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $5,119,552 | 178,506 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $4,299,642 | 179,376 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $3,028,224 | 178,551 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $2,531,611 | 170,824 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,459,500 | 156,258 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $4,166,694 | 154,551 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $5,582,847 | 150,847 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $7,145,976 | 149,560 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $4,893,974 | 144,621 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $5,721,123 | 138,526 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $5,892,305 | 135,830 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $5,021,101 | 117,042 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,570,136 | 33,593 | Shares | Sole | 2020-08-20 | |
| No filing history on record for this holder in this stock. | ||||||